After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
More about Vertex' Debbie Downer gene, Biogen's Alzheimer's spin and Sarepta caught in drug launch purgatory.
Eli Lilly (LLY) CEO John Lechleiter appeared on 'Bloomberg Daybreak: Americas' and discussed the Q3 financial results and the future of the company's animal health business.
Health care stocks in general are under pressure until after the U.S. presidential election, Cramer says.
Eli Lilly (LLY) reported lower-than-expected fiscal 2016 third-quarter results before today's market open.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.